AVITA Medical, Inc. Cash and Cash Equivalents
AVITA Medical, Inc. (AVHHL) had Cash and Cash Equivalents of $9.14 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $9.14M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $8.31M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $10.24M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $15.42M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $9.14M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $8.31M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $10.24M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $15.42M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $12.22M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $14.87M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $14.05M 10-K · filed 2026-02-12 |
| 2024-09-30 | $18.64M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $17.45M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $16.95M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $22.12M 10-K · filed 2025-02-13 |
| 2023-09-30 | $50.85M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $37.48M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $28.05M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $18.16M 10-K · filed 2024-02-22 |
| 2022-09-30 | $23.61M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $34.74M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $23.54M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $55.51M 10-K · filed 2023-02-23 |
| 2021-09-30 | $60.48M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $110.75M 10-K · filed 2023-02-23 |
| 2021-03-31 | $114.88M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $59.77M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $65.75M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $73.64M 10-KT · filed 2022-02-28 |
| 2019-06-30 | $20.17M 10-K · filed 2020-08-27 |